Edoardo Cignoli : Japanese Firm's Blood Thinner Appears Safer Than Standard Drug

Results from a highly anticipated study of Daiichi Sankyo's experimental drug to reduce blood clots showed that it appeared to work as well as the current standard treatment—though no better—and is safer.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887324886704579048742610386258.html?mod=pls_whats_news_us_business_f